Taking the lead: Avalo Therapeutics Inc (AVTX)

With 1.97 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.61 million shares. The 52-week range on AVTX shows that it touched its highest point at $1130.40 and its lowest point at $3.95 during that stretch. It currently has a 1-year price target of $180.00. Beta for the stock currently stands at 1.16.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AVTX was up-trending over the past week, with a rise of 266.80%, but this was up by 305.90% over a month. Three-month performance surged to 51.28% while six-month performance fell -47.25%. The stock lost -95.37% in the past year, while it has gained 96.70% so far this year.

Float and Shares Shorts:

At present, 0.80 million AVTX shares are outstanding with a float of 0.80 million shares on hand for trading. On Mar 15, 2024, short shares totaled 67180.0, which was 8.38% higher than short shares on Feb 15, 2024. In addition to AMTX as the firm’s Aemetis, Inc, AVTX serves as its Avalo Therapeutics, Inc.

Institutional Ownership:

Through their ownership of 8.12% of AVTX’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AVTX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, AVTX has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and AVTX currently yields $0.00. In the past year, AVTX’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, AVTX has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.